Mineral status and superoxide dismutase enzyme activity in Alzheimer’s disease

• Published in: Journal of trace elements in medicine and biology 2017-12, Vol.44, p.83-87
• Main Authors: Rodrigues, Gilmara Péres, Cozzolino, Silvia Maria Franciscato, Marreiro, Dilina do Nascimento, Caldas, Daniele Rodrigues Carvalho, da Silva, Kelcylene Gomes, de Sousa Almondes, Kaluce Gonçalves, Neto, José Machado Moita, Pimentel, José Alexandre Coelho, de Carvalho, Cecília Maria Resende Gonçalves, Nogueira, Nadir do Nascimento
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Alzheimer; Alzheimer Disease - blood; Alzheimer Disease - enzymology; Copper; Copper - blood; Copper - metabolism; Dementia; Demography; Female; Humans; Male; Middle Aged; Minerals - metabolism; Oxidative stress; Superoxide dismutase; Superoxide Dismutase - metabolism; Zinc; Zinc - blood; Zinc - metabolism
• ISSN: 0946-672X; 1878-3252
• DOI: 10.1016/j.jtemb.2017.06.005

The study evaluated the dietary intake of zinc and copper, as measured by plasma and erythrocyte concentrations, the Cu/Zn ratio and measure the erythrocyte superoxide dismutase enzyme (eSOD) activity and the relationship between these markers and the degree of dementia in elderly individuals with and without Alzheimer’s Disease (AD). A total of 93 elderly people aged 60–94 years were divided into two groups: with AD (n = 44) and without AD (n = 49). The NINCDS-ADRDA criteria were used for diagnosing AD, and dementia staging was determined using the Clinical Dementia Rating (CDR) scale. The dietary intake of Zn and Cu was obtained from a standard 3-day food record. Plasma and erythrocyte concentrations of the minerals were determined by flame atomic absorption spectrophotometry and by measuring eSOD activity in an automatic biochemical analyzer. The results showed dietary intake of Zn and Cu above the reference values with no differences observed between the two groups (p > 0.05). Plasma and erythrocyte normocupremia as well as alteration in the Zn pool, with its reduced plasma concentrations and high in the erythrocytes, were observed in both groups (p > 0.05). The plasma Cu/Zn ratio were not significantly different in patients with and without AD (p > 0.05). The eSOD activity was high in both patient groups (p > 0.05). However, among elderly patients with AD there was a positive correlation between this marker and dementia severity. According to our study results, we conclude that plasma and erythrocyte concentrations of Cu and Zn, as well as Cu/Zn ratio among elderly individuals is not related to Alzheimer’s Disease. However, antioxidant activity of eSOD is associated with dementia severity.